Characteristics of COVID-19 disease in multiple sclerosis patients

被引：21
|
作者：
Barzegar, Mahdi [1 ,2 ]
Mirmosayyeb, Omid [1 ,2 ,3 ]
Ghajarzadeh, Mahsa [3 ]
Nehzat, Nasim [1 ,3 ]
Vaheb, Saeed [1 ]
Shaygannejad, Vahid [1 ,2 ]
Vosoughi, Reza [4 ]
机构：
[1] Isfahan Univ Med Sci, Isfahan Neurosci Res Ctr, Esfahan, Iran
[2] Isfahan Univ Med Sci, Sch Med, Dept Neurol, Esfahan, Iran
[3] Univ Tehran Med Sci, Universal Council Epidemiol UCE, Univ Sci Educ & Res Network USERN, Tehran, Iran
[4] Univ Toronto, St Michaels Hosp, Multiple Sclerosis Clin, Toronto, ON, Canada
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 45卷
关键词：
D O I：
10.1016/j.msard.2020.102276
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Characteristics and Outcomes of 7620 Multiple Sclerosis Patients Admitted With COVID-19 in the United States
    Ramphul, Kamleshun
    Sombans, Shaheen
    Verma, Renuka
    Lohana, Petras
    Dhillon, Balkiranjit Kaur
    Gonzalez Mejias, Stephanie
    Sanikommu, Sailaja
    Ramphul, Yogeshwaree
    Pekyi-Boateng, Prince Kwabla
    NEUROHOSPITALIST, 2024, 14 (03): : 237 - 241
  • [22] COVID-19 pandemic: multiple sclerosis patients under disease-modifying therapies
    Berger, T.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 58 - 58
  • [23] Multiple sclerosis, rituximab, and COVID-19
    Langer-Gould, Annette
    Smith, Jessica B.
    Li, Bonnie H.
    Beaber, Brandon E.
    Brara, Sonu M.
    Debacker, Julie
    Nielsen, Allen Scott
    Amirova, Samira
    Ayeni, Oluwasheyi
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (04): : 938 - 943
  • [24] COVID-19 in cladribine-treated patients with multiple sclerosis
    Oreja-Guevara, C.
    Meca-Lallana, V.
    Brieva, L.
    Fernandez-Diaz, E.
    Garcia-Dominguez, J. M.
    Garcia-Estevez, D.
    Llorens, G.
    Moreno-Torres, I.
    Valenzuela, F. J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 59 - 60
  • [25] Impact of immunotherapies on COVID-19 outcomes in multiple sclerosis patients
    Zanetta, Chiara
    Rocca, Maria A.
    Filippi, Massimo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (05) : 495 - 512
  • [26] Impact of COVID-19 lockdown on progressive multiple sclerosis patients
    Vercellino, Marco
    Bosa, Chiara
    Alteno, Anastasia
    Schillaci, Valentina
    Petracca, Manuel
    Marasciulo, Stella
    Cavalla, Paola
    NEUROLOGICAL SCIENCES, 2022, 43 (05) : 2943 - 2946
  • [27] Multimodal Benefits of Exercise in Patients With Multiple Sclerosis and COVID-19
    Razi, Omid
    Tartibian, Bakhtyar
    Laher, Ismail
    Govindasamy, Karuppasamy
    Zamani, Nastaran
    Rocha-Rodrigues, Silvia
    Suzuki, Katsuhiko
    Zouhal, Hassane
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [28] COVID-19 in patients with multiple sclerosis-A narrative review
    Shrestha, Bijay Kumar
    Sujakhu, Eru
    Karale, Smruti
    Telagarapu, Venkata Madhavi Latha
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 93
  • [29] Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians
    Dyczkowska, Klara
    Kalinowska-Lyszczarz, Alicja
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2023, 57 (01) : 90 - 100
  • [30] COVID-19 Among Patients With Multiple Sclerosis A Systematic Review
    Barzegar, Mahdi
    Mirmosayyeb, Omid
    Gajarzadeh, Mahsa
    Afshari-Safavi, Alireza
    Nehzat, Nasim
    Vaheb, Saeed
    Shaygannejad, Vahid
    Maghzi, Amir-Hadi
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (04):
12345